Author(s):
Nurhikma Awaluddin, Muh. Akbar Bahar, Mukarram Mudjahid, Sartini Sartini, Aadilah Aadilah
Email(s):
hykma.awaluddin@gmail.com
DOI:
10.52711/0974-360X.2025.00827 
Address:
Nurhikma Awaluddin1,2*, Muh. Akbar Bahar1, Mukarram Mudjahid1, Sartini Sartini1, Aadilah Aadilah1,2
1Faculty of Pharmacy, Hasanuddin University, Makassar, South Sulawesi, Indonesia.
2Faculty of Pharmacy, Megarezky University, Makassar, South Sulawesi, Indonesia.
*Corresponding Author
Published In:
Volume - 18,
Issue - 12,
Year - 2025
ABSTRACT:
Preeclampsia (PE) is a pregnancy-specific complication characterized by vasospasm and endothelial damage, which can lead to maternal and fetal mortality. PE occurs before 34 weeks of gestation. One therapeutic approach involves the combination of nifedipine and magnesium sulfate, yet studies on its effectiveness and safety remain limited. This study evaluates the efficacy and safety of combining nifedipine and magnesium sulfate to lower blood pressure and prevent complications in patients with PE. It follows the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, with the research protocol registered in PROSPERO (CRD42024453927). A systematic review was conducted, analyzing experimental and observational clinical studies on this combination in preeclamptic pregnant women. A comprehensive literature search in PubMed and Embase on August 14, 2023, identified 874 articles, of which 18 (13 observational, 5 experimental) met the eligibility criteria for data analysis. Findings indicate that the combination effectively controls blood pressure and reduces the incidence of seizures, edema, and proteinuria. However, potential adverse effects include acute hypotension and neuromuscular blockade, which may lead to muscle paralysis. While nifedipine and magnesium sulfate may serve as a beneficial therapeutic option for preeclampsia, cautious use and close monitoring are essential. Further research is needed to confirm their long-term safety and efficacy.
Cite this article:
Nurhikma Awaluddin, Muh. Akbar Bahar, Mukarram Mudjahid, Sartini Sartini, Aadilah Aadilah. The Effectiveness and Safety of Nifedipine and Magnesium Sulfate Combination in Managing Preeclampsia. Research Journal Pharmacy and Technology. 2025;18(12):5729-8. doi: 10.52711/0974-360X.2025.00827
Cite(Electronic):
Nurhikma Awaluddin, Muh. Akbar Bahar, Mukarram Mudjahid, Sartini Sartini, Aadilah Aadilah. The Effectiveness and Safety of Nifedipine and Magnesium Sulfate Combination in Managing Preeclampsia. Research Journal Pharmacy and Technology. 2025;18(12):5729-8. doi: 10.52711/0974-360X.2025.00827 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-12-17
REFERENCES:
1. Rana S, Lemoine E, Granger J, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019; 124(7): 1094–112. 1. https://doi.org/10.1161/CIRCRESAHA.118.313276
2. Kb N, S SP, Karunanithi K. A comparative study of IV labetalol with oral nifedipine in severe preeclampsia. International Journal of Clinical Obstetrics and Gynaecology. 2020; 4(1): 388–92. https://doi.org/10.33545/gynae.2020.v4.i1f.491
3. Cleary EM, Racchi NW, Patton KG, Kudrimoti M, Costantine MM, Rood KM. Trial of Intrapartum Extended-Release Nifedipine to Prevent Severe Hypertension among Pregnant Individuals with Preeclampsia with Severe Features. Hypertension. American Heart Association. 2023; 80(2): 335–42. https://doi.org/10.1161/HYPERTENSIONAHA.122.19751
4. Jazna PB, Jebakumari R, Santha NJ. A Study to Assess the Effectiveness of Benson Relaxation Therapy on Blood Pressure and Stress among Women with Pregnancy Induced Hypertension in Selected Hospitals, Madurai. Asian J Nurs Educ Res. 2016; 6(2): 167. https://doi.org/10.5958/2349-2996.2016.00031.8
5. Zuwanda, Janitra R. Diagnosis dan Penatalaksanaan. Cdk. 2013; 40(9): p. 661–673.
6. Batmomolin A, Khotimah H, Ahsan A, Wiyasa IWA, Santoso S. Effects of quercetin and kaempferol (Main compound of moringa oleifera leaves) improve IUGR through decreased hypoxia. Res J Pharm Technol. 2020; 13(12): 5831–6. https://doi.org/10.5958/0974-360X.2020.01016.1
7. ACOG. The American College of Obstetricians and Gynecologists, 2020.Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstet Gynecol. 2020; 135(6): 1492–5. https://doi.org/10.1097/AOG.0000000000003891
8. Yu X, Zhou Q. Effects of Nifedipine Tablets Combined With Magnesium Sulfate on Blood Coagulation Index, Oxidative Stress, NO and ET-1 Levels in Patients With Pregnancy Hypertension. Front Surg. 2022; 9(March): 1–9. https://doi.org/10.3389/fsurg.2022.862676
9. ACOG. Clinical Management Guidelines For Obstretrician-Gynecologists. Obstet Gynecol. 2019; 133(76): 168–86. https://doi.org/10.1097/AOG.0000000000003018
10. Sharma DD, Chandresh NR, Javed A, Girgis P, Zeeshan M, Fatima SS, et al. The Management of Preeclampsia: A Comprehensive Review of Current Practices and Future Directions. Cureus. 2024; 16(1): 1–10. https://doi.org/10.7759/cureus.51512
11. Xiang C, Zhou X, Zheng X. Magnesium Sulfate in combination with Nifedipine in the treatment of Pregnancy-Induced Hypertension. Pak J Med Sci. 2020; 36(2): 21–5. https://doi.org/10.12669/pjms.36.2.706
12. Pasaribu HP, Hariman H, Roeshadi RH, Koh SCL. Soluble vascular cell adhesion molecule-1 and magnesium sulfate with nifedipine treatment in Indonesian women with severe pre-eclampsia. Interv Med Appl Sci. 2016; 8(3): 97–102. 12.https://doi.org/10.1556/1646.8.2016.3.4
13. Vivekanandan K, Harikrishnan N, Bhavya E, Babu P, Nandhakumar S. Formulation and evaluation of floating drug delivery of an anti-hypertensive drug. Res J Pharm Technol. 2018; 11(11): 4785–96.https://doi.org/10.5958/0974-360X.2018.00871.5
14. Wang Y, Zhang X, Han Y, Yan F, Wu R. Efficacy of combined medication of nifedipine and magnesium sulfate on gestational hypertension and the effect on PAPP-A, VEGF, NO, Hcy and vWF. Saudi J Biol Sci. 2019; 26(8): 2043–7.https://doi.org/10.1016/j.sjbs.2019.08.012
15. Rajanit S, Paras V, Raj H. Absorption Correction Method for Simultaneous Estimation of Nifedipine and Metoprolol Succinate in Their Synthetic Mixture Using From Spectrophotometry. Asian J Pharm Technol. 2015; 5(1): 13. https://doi.org/10.5958/2231-5713.2015.00003.3
16. Magee LA, Miremadi S, Li J, Cheng C, Ensom MHH, Carleton B, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol. 2005; 193(1): 153–63.https://doi.org/10.1016/j.ajog.2004.11.059
17. Harsono AAH, Achmadi A, Akbar MIA, Joewono HT. Recurrent seizures in 2 patients with magnesium sulfate-treated eclampsia at a secondary hospital. Am J Case Rep. 2018;19:1129–34.https://doi.org/10.12659/AJCR.911004
18. Snyder SW, Cardwell MS. Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol. 1989; 161(1): 35–6.https://doi.org/10.1016/0002-9378(89)90226-3
19. M. BEN-AMI Consultant, Y. GILADI Registrar ES. The combination of magnesium sulphate and nifedipine : a cause of neuromuscular blockade. Br J Obstet Gynaecol. 1994;Vol. 101,: 262–3. https://doi.org/10.1111/j.1471-0528.1994.tb13126.x
20. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev [Internet]. 2016; 5(1): 1–10. Available from: http://dx.doi.org/10.1186/s13643-016-0384-4
21. Cohen J. A Coefficient of Agreement for Nominal Scales. Educ Psychol Meas. 1960; 20(1): 37–46. https://doi.org/10.1177/001316446002000104
22. Waisman GD, Mayorga LM, Camera MI, Vignoio CA, Martinotti A. Magnesium Plus nifedipine: Potentiation of hypotensive effect in preeclampsia? Am J Obstet Gynecol. 1988; 159(2): 308–9. https://doi.org/10.1016/s0002-9378(88)80072-3
23. Chhabra S, Goyal D, Kakani A. Need for relooking into management of eclampsia. Asian Pacific J Trop Dis. 2011; 1(3): 241–4. https://doi.org/10.1016/S2222-1808(11)60039-X
24. Abd El Aal DEM, Shahin AY. Management of eclampsia at Assiut University Hospital, Egypt. Int J Gynecol Obstet. 2012; 116(3): 232–6. https://doi.org/10.1016/j.ijgo.2011.10.018
25. Xiao CW, Gangal M, Abenhaim HA. Effect of magnesium sulfate and nifedipine on the risk of developing pulmonary edema in preterm births. J Perinat Med. 2014; 42(5): 585–9. https://doi.org/10.1515/jpm-2013-0340
26. Zhao F, Ai F, Wu J, Dong X. Changes and clinical significance of serum inflammatory factors in the treatment of pregnancy hypertension syndrome with magnesium sulfate combined with nifedipine. Exp Ther Med. 2020; 20(2): 1796–802. https://doi.org/10.3892/etm.2020.8863
27. Richter AE, Schat TE, Van Braeckel KNJA, Scherjon SA, Bos AF, Kooi EMW. The Effect of Maternal Antihypertensive Drugs on the Cerebral, Renal and Splanchnic Tissue Oxygen Extraction of Preterm Neonates. Neonatology. 2016; 110(3): 163–71. https://doi.org/10.1159/000445283
28. Scardo JA, Vermillion ST, Hogg BB, Newman RB, Kotzen JH, Thorp J, et al. Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies. Am J Obstet Gynecol. 1996; 175(2): p. 336–40.
29. Wu Y, Wang DJ, Zhang Y, Zhang YX, Zhang R. Regulation of magnesium sulfate combined with nifedipine and labetalol on disease-related molecules in serum and placenta in the treatment of preeclampsia. Eur Rev Med Pharmacol Sci. 2020; 24(9): 5062–70. https://doi.org/10.26355/eurrev_202005_21199
30. Bhalla AK, Dhall GI, Dhall K. A Safer and More Effective Treatment Regimen for Eclampsia. Aust New Zeal J Obstet Gynaecol. 1994; 34(2): 144–8. https://doi.org/10.1111/j.1479-828X.1994.tb02677.x
31. How HY, Zafaranchi L, Stella CL, Recht K, Maxwell RA, Sibai BM, et al. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: A randomized controlled pilot study. Am J Obstet Gynecol. 2006; 194(4): 976–81. https://doi.org/10.1016/j.ajog.2006.02.030
32. Koontz SL, Friedman SA, Schwartz ML. Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine. Am J Obstet Gynecol. 2004; 190(6): 1773–6. https://doi.org/10.1016/j.ajog.2004.02.050
33. Moriwaki K, Kayashima K. Prolonged neuromuscular blockade and insufficient reversal after sugammadex administration in cesarean section under general anesthesia: a case report. JA Clin Reports. 2019; 5(1): 8–11. https://doi.org/10.1186/s40981-019-0248-8
34. Nagpal A. Comprehensive Evidence Analysis for Interventional Procedures Used to Treat Chronic Pain, An Issue of Physical Medicine and Rehabilitation Clinics of North America, E-Book: Comprehensive Evidence Analysis for Interventional Procedures Used to Treat Chroni. Elsevier Health Sciences; 2022. (The Clinics: Internal Medicine). https://books.google.co.id/books?id=imdxEAAAQBAJ.
35. Xiaolin Z, Xian C, Tanchu Y, Qi Z. Efficacy of magnesium sulfate combined with nifedipine for pregnancy-induced hypertension syndrome and its relation to glucose and lipid metabolism. Am J Transl Res. 2023; 15(9): p. 5940–8.
36. Drugs.com. www.drugs.com. 2023. Magnesium Sulfate in Dextrose Injection Prescribing Information. https://www.drugs.com/pregnancy/magnesium-sulfate.html
37. Veena P, Raghavan Ss. Synergistic effect of nifedipine and magnesium sulfate causing symptomatic hypocalcemia in a preeclamptic patient. Int J Adv Med Heal Res. 2016; 3(2): 105. http://dx.doi.org/10.4103/2349-4220.195942